GPCR Consortium Locks In First Corporate Partners
This article was originally published in PharmAsia News
Executive Summary
A new multinational industry-academia consortium set up to elucidate the structures of G protein-coupled receptors (GPCRs) has confirmed its first corporate partners, with one Japanese pharma firm and two research institutes in Shanghai among the founder members of the initiative.